Authors' response to Dr Reiter
نویسندگان
چکیده
منابع مشابه
Authors reply to Dr. Kawada's comments.
We thank Dr. Kawada for his insightful comments [1] on our study [2], which highlights the importance of the C-reactive protein (CRP) concentration as a significant risk marker for metabolic syndrome (MetS). Dr. Kawada argued that stratified analyses by gender for the association between CRP concentrations and MetS should be performed in our study, given that there were gender differences in th...
متن کاملAuthors' Reply to Comments from Dr. Guan
To the Editor. We thank Dr. Guan for his interest in our recent article [1]. He has raised some comments regarding possible potential of MT and zinc as therapeutic tools for inflammatory diseases. As he mentions, simply inducing and/or enhancing metallothionein (MT) is harmful, particularly in physiological condition. We want to emphasize that for severe (lethal) inflammatory conditions such as...
متن کاملResponse to Dr .
TO THE EDITOR: We thank Dr. Kawada for his interest in our recent article (5) and for raising several important issues related to the analysis of actigraphy in alcoholics. First, as noted in his letter we did use the default setting of 40 for sleep/wake sensitivity. We did this to permit comparison with our other studies and with the general literature, which largely tends to use this setting (...
متن کاملResponse to Dr. Olshansky.
I enjoyed Dr. Olshansky’s gloomy take on the data relating to healthy life expectancy (HLE). As usual with his writings, the essay is clear and thoughtful, but the available data do not support his pessimistic conclusions. First he sets up a straw man offering that, “life extension in the future would probably not yield the same amount of healthy life as it did in the 1980s,” but our argument i...
متن کاملResponse to Dr. Clarfield.
I would like to thank Dr. Clarfield for providing an enlightening essay on trends in healthy life expectancy (HLE). He opened my eyes to alternative ways of thinking about these metrics, but before I get into this important issue, it is worth clarifying one main point raised during this debate. Dr. Clarfield states, “Life expectancy is increasing at all ages in the developed world and has been ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: British Journal of Clinical Pharmacology
سال: 2012
ISSN: 0306-5251
DOI: 10.1111/j.1365-2125.2012.04322.x